PLAU and kidney disorder: However, several shortcomings can be highlighted regarding the uPA-SCID mouse model: high neonatal lethality, a tendency to develop kidney disorders, lower body size, reduction of donor hepatocytes (even in homozygotes), less efficient breeding, technically challenging surgical manipulation in young and fragile mice, and finally the inability to expand engrafted hepatocytes (83, 88, 93–96).